POLYCYSTIN-1 MEDIATED CALCIUM AND cAMP SIGNALING

一些观察结果表明，cAMP是PKD发病机制的核心，通过激活Ras/MAPK通路导致囊肿形成和囊肿生长所需的细胞增殖，并通过激活CFTR刺激液体分泌来填充囊肿。最近，在四种动物模型中，使用抗利尿激素V2受体拮抗剂成功治疗PKD，进一步证实了cAMP的重要性，该拮抗剂可能降低了肾脏cAMP。然而，尽管这些实验支持cAMP很重要的观点，但尚不清楚多囊素中的缺陷如何导致cAMP介导的与细胞增殖增加和囊肿增大相关的机制失调。多囊毒素被认为在响应配体介导或机械感觉刺激时调节细胞内Ca2+水平。最近,我们

Several observations have suggested that cAMP is central to the pathogenesis of PKD, by activating the Ras/MAPK pathway resulting in the cell proliferation required for cyst formation and cyst growth, and by activating CFTR to stimulate fluid secretion to fill cysts. The importance of cAMP was recently further confirmed by the successful treatment of PKD in four animal models, using a vasopressin V2 receptor antagonist which presumably lowered renal cAMP. However, while these experiments support the view that cAMP is important, it is not known how a defect in the polycystins causes misregulation of cAMP-mediated mechanisms associated with increased cell proliferation and cyst enlargement. The polycystins are thought to regulate intracellular Ca2+ levels in response to ligand-mediated or mechanosensory stimuli. Recently, we showed that polycystin-1 alone is capable of elevating intracellular Ca2+ through a heterotrimeric G protein-coupled mechanism. We have also shown, using three cell culture model systems, that PKD-like cell proliferation is dependent on cAMP-mediated activation of the Ras/MAPK pathway and to changes in Ca2+-dependent gene expression. All three systems displayed the same phenotypic switch from cAMP-inhibited to cAMP-stimulated cell proliferation. Yet, despite these observations, it is still not clear whether and how the polycystins may be involved. As such, we plan to determine if the PKD-like cAMP-stimulated phenotype is a characteristic of Pkd1 deficient cells. We will use the Pkd1(m1Bei) mouse, which has a single amino acid missense mutation and a full-blown PKD phenotype, and we plan to generate two new mouse models, Pkd1(DeltaL) and Pkd1(Gpro), which will carry, respectively, a single amino acid (aa) deletion mutation in the heterotrimeric G protein binding region of polycystin-1 mimicking a known human mutation, or a 52 aa frameshift mutation in the heterotrimeric G protein binding region of polycystin-1. We also plan to utilize metanephric kidney cultures from these mice to determine whether the PKD-like phenotypic switch occurs in embryonic kidney cells at a time when cysts begin to grow in Pkd1-deficient mouse models and in human ADPKD. Finally, we plan to test polycystin-1 mediated signaling activity under conditions of fluid flow mediated ciliary bending to determine if polycystin-1 can generate a Ca2+ signal sufficient to alter Ca2+- dependent gene expression.